129 related articles for article (PubMed ID: 6805245)
1. Ultrastructure of cervical mucus and sperm penetration during use of a triphasic oral contraceptive.
Ulstein M; Myklebust RU
Acta Obstet Gynecol Scand Suppl; 1982; 105():45-9. PubMed ID: 6805245
[TBL] [Abstract][Full Text] [Related]
2. [Results of in vitro sperm penetration tests in cervical mucus under takings of the sequential oral contraceptive ovanon and sequilar (author's transl)].
Bregulla K; Fröhlich M
Arch Gynakol; 1977 Oct; 223(3):187-93. PubMed ID: 579297
[TBL] [Abstract][Full Text] [Related]
3. Spermagglutinating antibodies and sperm penetration of cervical mucus from infertile women with spermagglutinating antibodies in serum.
Ingerslev HJ
Fertil Steril; 1980 Dec; 34(6):561-8. PubMed ID: 7450075
[TBL] [Abstract][Full Text] [Related]
4. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
Masson S; Franssen E; Hilditch JR; Powell MG
Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
6. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
Carlborg L
Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
[TBL] [Abstract][Full Text] [Related]
7. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
[TBL] [Abstract][Full Text] [Related]
8. Effects of norgestimate in combination with ethinyl estradiol on cervical mucus.
Mohsenian M; Moghissi KS; Borin K
Contraception; 1981 Aug; 24(2):173-81. PubMed ID: 7297068
[TBL] [Abstract][Full Text] [Related]
9. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
[TBL] [Abstract][Full Text] [Related]
11. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
Miller JF; Fotherby K; Bye PG; Elstein M
Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Gaspard UJ; Deville JL; Dubois M
Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
[TBL] [Abstract][Full Text] [Related]
13. Experimental study of cervical blockage induced by continuous low-dose oral progestogens.
Chretien FC; Sureau C; Neau C
Contraception; 1980 Nov; 22(5):445-56. PubMed ID: 6894112
[TBL] [Abstract][Full Text] [Related]
14. Results of in vitro sperm penetration tests in cervical mucus in the normal cycle and in mucus under the influence of the contraceptive pill.
Bregulla K; Hausser H
Arch Gynakol; 1975 Jul; 218(3):227-32. PubMed ID: 1174309
[TBL] [Abstract][Full Text] [Related]
15. Temporal relationship between Uniplant insertion and changes in cervical mucus.
Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
[TBL] [Abstract][Full Text] [Related]
16. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
17. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
[TBL] [Abstract][Full Text] [Related]
18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
19. Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro.
Croxatto HB; Díaz S; Salvatierra AM; Morales P; Ebensperger C; Brandeis A
Contraception; 1987 Aug; 36(2):193-201. PubMed ID: 3123133
[TBL] [Abstract][Full Text] [Related]
20. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
